Safety, Tolerability, and Efficacy of MatriPlax in Subjects With Acute Respiratory Distress Syndrome

NCT05886985 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Respiratory Distress Syndrome

Interventions

DRUG: MatriPlax

Sponsor

BioSpring Medical Co., Ltd